期刊
CELL REPORTS
卷 18, 期 13, 页码 3204-3218出版社
CELL PRESS
DOI: 10.1016/j.celrep.2017.03.018
关键词
-
类别
资金
- NIH [5R00-CA151670-05]
- V Foundation Scholar
- Knight Cancer Institute Pilot Project
- NIH/NCI [5R01-CA183974-03]
- NSF Graduate Research Fellowship [DGE-1448072]
Secreted proteins in the bone marrow microenvironment play critical roles in acute myeloid leukemia (AML). Through an ex vivo functional screen of 94 cytokines, we identified that the pro-inflammatory cytokine interleukin-1 (IL-1) elicited profound expansion of myeloid progenitors in similar to 67% of AML patients while suppressing the growth of normal progenitors. Levels of IL-1 beta and IL-1 receptors were increased in AML patients, and silencing of the IL-1 receptor led to significant suppression of clonogenicity and in vivo disease progression. IL-1 promoted AML cell growth by enhancing p38MAPK phosphorylation and promoting secretion of various other growth factors and inflammatory cytokines. Treatment with p38MAPK inhibitors reversed these effects and recovered normal CD34(+) cells from IL-1-mediated growth suppression. These results highlight the importance of ex vivo functional screening to identify common and actionable extrinsic pathways in genetically heterogeneous malignancies and provide impetus for clinical development of IL-1/IL1R1/p38MAPK pathway-targeted therapies in AML.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据